Italian Sunshine Reporting. Is it Time to Pay Attention?

June 20th, 2024

10:00 am –  11:00 am EST (Eastern Standard Time)
04:00 pm – 05:00 pm CET (Central European Time)

Register Now

About the Webinar:


Join us for an impactful webinar featuring Edoardo Lazzarini, a global transparency expert from Milan, Italy, with deep knowledge of the Italian pharmaceutical life sciences industry. He will discuss the Italian Sunshine Act and its impact on the Italian healthcare landscape. This new legislation, Law No. 62 of May 31, 2022, is a game-changer for transparency and accountability.

Joining Edoardo Lazzarini on our expert panel is Ned Mumtaz, former director, Otsuka and Pfizer, having an experience of over 30 years in pharmaceutical compliance. Together, they will guide you through the key provisions of the Italian Sunshine Act, helping you navigate:

  • The Public Telematic Registry – “Transparent Health”: What is expected in this new registry and how to prepare to collect data?
  • Compliance Requirements: Demystifying your communication obligations and potential consequences for non-compliance.
  • Q&A: Join our live Q&A session and get expert insights directly from the source.

This webinar is a must-attend for:

  • Compliance Officers & Managers: Expanding globally? Ensure a smooth transition into the Italian market.
  • Regulatory Affairs Professionals: Stay ahead of the curve and understand the evolving international compliance landscape.
  • Corporate Legal Advisors: Deepen your knowledge of global transparency and reporting requirements.
  • Biotech & Life Sciences Executives: Gain valuable insights as you navigate your global market presence.

Don’t miss this opportunity to shine a light on your Italian healthcare operations! Register for the free webinar today!


Edoardo Lazzarini

Edoardo Lazzarini has over 25 years of experience in the pharmaceutical industry in Italy with Merck, Takeda, Zimmer, and GSK (Haleon).

Most recently he oversaw the implementation of business ethics & compliance programs for GSK (Haleon). Edoardo was awarded the “Leadership in the Advancement of Ethics” award; he was Vice Chair of the Compliance Network in MedTech Europe and a member of “B20 Integrity & Compliance Taskforce”. Edoardo is deeply familiar with Farma Industria, and additionally, he teaches at a graduate college, speaks at compliance conferences, and regularly writes on compliance, anti-corruption, and the Italian Sunshine Act.

Ned Mumtaz

Compliance Director, Vector Health
Former Director of Pfizer

Ned joined Vector Health as a Partner/Director in January 2020. He has extensive experience in the pharmaceutical industry, having served as a Director at Otsuka and Wyeth, and an Associate Director at Eisai Pharmaceuticals and Schering Plough. Ned has served over 150 drug and device manufacturers, including Pfizer, Wyeth, Novartis, and Zimmer.